| 2010-11 | 2011-12 | 2012-13 | 2013-14 | 2014-15 | |
|---|---|---|---|---|---|
| Sales | 70.01 | 17.41 | 30.44 | 27.56 | 40.77 |
| Other income | 8.64 | 5.77 | 1.72 | 23.87 | 3.45 |
| Opex | 183.52 | 70.09 | 173.57 | 186.68 | 100.97 |
| EBIDTA | -104.87 | -46.91 | -141.41 | -135.25 | -56.75 |
| Exceptional Items | 230.1 | 15.74 | 63.95 | 10.87 | 140.35 |
| EBIDTA after exceptional items | -334.97 | -62.65 | -205.36 | -146.12 | -197.1 |
| Interest | -334.97 | -62.65 | -205.36 | -146.12 | -197.1 |
| Depreciation | 8.03 | 5.05 | 14.71 | 46.86 | 66.47 |
| EBT | -378.38 | 102.63 | -255.22 | -228.54 | -304.14 |
| Accumulated losses | -889.72 | -992.35 | -1247.57 | -1476.11 | -1781.17 |
| Total Assets | 727.02 | 684.36 | 669.95 | 701.9 | 637.13 |
| Total Liabilities | 108.14 | 168.1 | 408.91 | 669.41 | 909.71 |
| Net worth | 618.88 | 516.26 | 261.04 | 32.49 | -272.58 |
